Systematic Phenotyping and Characterization of the 5xFAD mouse model of Alzheimer's Disease
Forner, S.; Kawauchi, S.; Balderrama-Gutierrez, G.; Kramar, E. A.; Matheos, D. P.; Phan, J.; Javonillo, D. I.; Minh Tran, K.; Hingco, E.; da Cunha, C.; Rezaie, N.; Alcantara, J. A.; Baglietto-Vargas, D.; Jansen, C.; Neumann, J.; Wood, M. A.; MacGregor, G. R.; Mortazavi, A.; Tenner, A. J.; LaFerla, F. M.; Green, K. N.
Show abstract
Mouse models of human diseases are invaluable tools for studying pathogenic mechanisms and testing interventions and therapeutics. For disorders such as Alzheimers disease in which numerous models are being generated, a challenging first step is to identify the most appropriate model and age to effectively evaluate new therapeutic approaches. Here we conducted a detailed phenotypic characterization of the 5xFAD model on a congenic C57BL/6J strain background, across its lifespan - including a seldomly analyzed 18-month old time point to provide temporally correlated phenotyping of this model and a template for characterization of new models of LOAD as they are generated. This comprehensive analysis included quantification of plaque burden, A{beta} biochemical levels, and neuropathology, neurophysiological measurements and behavioral and cognitive assessments, and evaluation of microglia, astrocytes, and neurons. Analysis of transcriptional changes was conducted using bulk-tissue generated RNA-seq data from microdissected cortices and hippocampi as a function of aging, which can be explored at the UCI Mouse Explorer and AD Knowledge Portal. This deep-phenotyping pipeline identified novel aspects of age-related pathology in the 5xFAD model.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer's-like pathology 97%
- Muscle Cathepsin B treatment improves behavioral and neurogenic deficits in a mouse model of Alzheimer's Disease 97%
- S100A8-enriched microglia populate the brain of tau-seeded and accelerated aging mice 96%
Similar papers in this journal
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 98%
- TREM2-H157Y Increases Soluble TREM2 Production and Reduces Amyloid Pathology 97%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
Similar papers in this journal
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43. 95%
- Immune receptor LAG3 regulates microglia function duringAlzheimer's disease 94%
Similar papers in this journal
- Amelioration of symptomatic Alzheimer's Disease after selective impairment of p75NTR function in adult forebrainexcitatory neurons 97%
- Heightened β-adrenergic receptor function in the TgF344-AD rat model drives synaptic potentiation and supports learning and memory 96%
- Genetic mapping of APP and amyloid-β biology modulation by trisomy 21 95%